Blood pressure control in conventional hemodialysis.

abstract：:Until the discovery of calcimimetics, the management of secondary hyperparathyroidism (SHPT) relied exclusively on treatment with phosphate binders, vitamin D derivatives or surgical parathyroidectomy with limited success. The therapeutic use of calcimimetic agents, together with a better understanding of the pivotal ...

journal_title：Seminars in dialysis

authors： Rodríguez M,Goodman WG,Liakopoulos V,Messa P,Wiecek A,Cunningham J

更新日期：2015-09-01 00:00:00

abstract：:As suggested by its American brand name (Sensipar), the calcimimetic cinacalcet sensitizes the parathyroid cells to the extracellular calcium signal, suppressing parathyroid hormone (PTH) release and synthesis and preventing parathyroid cell proliferation. This primary PTH suppression decreases the release of calcium ...

journal_title：Seminars in dialysis

authors： Shahapuni I,Mansour J,Harbouche L,Maouad B,Benyahia M,Rahmouni K,Oprisiu R,Bonne JF,Monge M,El Esper N,Presne C,Moriniere P,Choukroun G,Fournier A

更新日期：2005-05-01 00:00:00

abstract：:In patients receiving hemodialysis, the provision of safe and effective vascular access using an arteriovenous fistula or graft is regarded as a critical priority by patients and health professionals. Vascular access failure is associated with morbidity and mortality, such that strategies to prevent these outcomes are...

journal_title：Seminars in dialysis

authors： Viecelli AK,Mori TA,Roy-Chaudhury P,Polkinghorne KR,Hawley CM,Johnson DW,Pascoe EM,Irish AB

更新日期：2018-05-01 00:00:00

abstract：:National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI) guidelines recommend Doppler ultrasound (DU) for surveillance of vascular access (VA), but trials have not been unanimous about its benefit on VA patency. The aim of this study was to evaluate the accuracy of DU for patency, as well as t...

journal_title：Seminars in dialysis

authors： Guedes Marques M,Ibeas J,Botelho C,Maia P,Ponce P

更新日期：2015-03-01 00:00:00

abstract：:Concern over the inherent inefficiency of solute removal by conventional peritoneal dialysis (PD) has led to renewed interest in continuous flow PD (CFPD). We present clinical data from two experiences with CFPD. In the first, two catheters were used to recirculate a fixed intraperitoneal volume through an external ci...

journal_title：Seminars in dialysis

authors： Amerling R,DeSimone L,Inciong-Reyes R,Pangilinan A,Folden T,Ronco C,Gotch FA,Levin N

更新日期：2001-09-01 00:00:00

abstract：:A good catheter implantation technique is important to allow for effective peritoneal access function and long-term technique survival. Studies regarding results obtained by nephrologists in comparison with surgeons have been limited to small single-center experiences. Thus, the objective of this study was to explore ...

journal_title：Seminars in dialysis

authors： de Moraes TP,Campos RP,de Alcântara MT,Chula D,Vieira MA,Riella MC,Olandowski M,Divino-Filho JC,Pecoits-Filho R,Investigators of BRAZPD.

更新日期：2012-09-01 00:00:00

abstract：:We present a case of arteriovenous graft pseudoaneurysms treated endovascularly with stent grafts and make suggestions regarding the technique of evaluating the pseudoaneurysms and choosing the proper location to deploy the stent grafts to maximize the outcomes and minimize the length of the graft covered by the stent...

journal_title：Seminars in dialysis

authors： Florescu MC,Fillaus JA,Plumb TJ

更新日期：2014-03-01 00:00:00

abstract：:Secondary hyperparathyroidism almost universally accompanies end-stage renal disease (ESRD). In some, but not all studies, elevated serum parathyroid hormone (PTH) concentrations are associated with increased fracture rates, cardiovascular disease, and mortality in ESRD. The serum concentration of PTH required for opt...

journal_title：Seminars in dialysis

authors： Zand L,Kumar R

更新日期：2016-05-01 00:00:00

abstract：:Thrombosis is the leading cause of arteriovenous (AV) access failure for hemodialysis patients requiring frequent interventions. We describe a novel approach to the lyse-and-wait technique in thrombosed AV access using nurse-administered thrombolytics in a hospital-based hemodialysis unit. All patients at a single-cen...

journal_title：Seminars in dialysis

authors： Umanath K,Morrison RS,Christopher Wilbeck J,Schulman G,Bream P,Dwyer JP

更新日期：2013-01-01 00:00:00

abstract：:Anemia is a common complication of advanced chronic kidney disease (CKD). Treatment with erythropoiesis-stimulating agents (ESAs) remains a common approach in managing anemia of CKD. The 2012 Kidney Disease Improving Global Outcomes Clinical Practice Guideline for Anemia in CKD suggests avoiding ESA therapy use to mai...

journal_title：Seminars in dialysis

authors： Shah HH,Fishbane S

更新日期：2018-07-01 00:00:00

abstract：:Analysis of tissues, plasma, urine, other body fluids, and dialysate for glycation adducts has revealed the presence of two major forms: glycation adduct residues of proteins and related glycated amino acids--called glycation free adducts. The major effect on protein glycation in uremia is loss of clearance of glycati...

journal_title：Seminars in dialysis

authors： Thornalley PJ,Rabbani N

更新日期：2009-07-01 00:00:00

abstract：:While patients with sickle cell disease currently constitute a very small minority of the US dialysis population (0.1%), there is anticipated growth of this group as the life expectancy of those with sickle cell disease (SCD) increases. SCD patients suffer a high burden of morbidity, which is enhanced by the presence ...

journal_title：Seminars in dialysis

authors： Boyle SM,Jacobs B,Sayani FA,Hoffman B

更新日期：2016-01-01 00:00:00

abstract：:Depression has been documented as the most frequently encountered psychological problem in end-stage renal disease (ESRD) patients and has been correlated with both mortality and morbidity in these patients. Previous work by our group has shown that clinical depression is treatable with psychotropic medications in the...

journal_title：Seminars in dialysis

authors： Wuerth D,Finkelstein SH,Kliger AS,Finkelstein FO

更新日期：2003-11-01 00:00:00

abstract：:Treatment of thrombosed dialysis ateriovenous (AV) grafts in the radiology interventional suite requires percutaneous mechanical thrombectomy, along with angioplasty of the underlying stenotic lesion. We analyzed the anatomic reasons for unsuccessful percutaneous thrombectomy of AV grafts, and assessed the feasibility...

journal_title：Seminars in dialysis

authors： Maya ID,Smith T,Young CJ,Allon M

更新日期：2008-03-01 00:00:00

abstract：:Peritoneal dialysis (PD) is a markedly underutilized modality for permanent renal replacement therapy in the United States owing to a low rate of patient referral and high rate of patient dropout or transfer to hemodialysis. One cause for patient loss from PD is problematic PD catheters that often are removed rather t...

journal_title：Seminars in dialysis

authors： Asif A,Gadalean F,Vieira CF,Hogan R,Leon C,Merrill D,Ellis R,Amador A,Broche O,Bush B,Contreras G,Pennell P

更新日期：2006-03-01 00:00:00

abstract：:Home dialysis (home HD or home PD) remains underutilized in most jurisdictions. Physicians, advanced-practice nurses, and policy makers working with chronic kidney disease populations can provide insights into patient, healthcare professional, and system-level barriers to home dialysis selection by suitable patients. ...

journal_title：Seminars in dialysis

authors： Osterlund K,Mendelssohn D,Clase C,Guyatt G,Nesrallah G

更新日期：2014-03-01 00:00:00

abstract：:Cardiovascular morbidity and mortality remain frustratingly common in dialysis patients. A dearth of established evidence-based treatment calls for alternative therapeutic avenues to be embraced. Sympathetic hyperactivity, predominantly due to afferent nerve signaling from the diseased native kidneys, has been establi...

journal_title：Seminars in dialysis

authors： Hoye NA,Wilson LC,Jardine DL,Walker RJ

更新日期：2019-05-01 00:00:00

abstract：:This review aims to summarize the available evidence of the effectiveness of oral iron in patients receiving dialysis. Four small randomized controlled trials (105 evaluated patients) compared oral iron supplements with placebo or no treatment; hemoglobin and ferritin levels did not differ significantly between groups...

journal_title：Seminars in dialysis

authors： Hodson EM,Craig JC

更新日期：2014-01-01 00:00:00

abstract：:Determining dry weight and assessing extracellular fluid volume in hemodialysis (HD) patients is one of the greatest challenges to practicing nephrologists. The clinical examination has limited accuracy, so different strategies have been investigated to aid in this evaluation. Biochemical markers of volume overload (A...

journal_title：Seminars in dialysis

authors： Ishibe S,Peixoto AJ

更新日期：2004-01-01 00:00:00

abstract：:Dialysate leakage represents a major noninfectious complication of peritoneal dialysis (PD). An exit-site leak refers to the appearance of any moisture around the PD catheter identified as dialysate; however, the spectrum of dialysate leaks also includes any dialysate loss from the peritoneal cavity other than via the...

journal_title：Seminars in dialysis

authors： Leblanc M,Ouimet D,Pichette V

更新日期：2001-01-01 00:00:00

abstract：:The dialysis industry is one of the most highly concentrated healthcare sectors in the United States. Despite decades of growth in the number of patients with end-stage renal disease and in the size of dialysis markets, two large dialysis organizations currently care for more than two-thirds of the dialysis population...

journal_title：Seminars in dialysis

authors： Saeed MK,Ho V,Erickson KF

更新日期：2020-01-01 00:00:00

abstract：:Patients with end-stage renal disease are more likely to suffer from gastrointestinal (GI) problems, including bleeding from upper and lower sources. Peptic ulcer disease is the most common cause of upper GI bleeding, and although there is some debate in the literature regarding whether the frequency of ulcer disease ...

journal_title：Seminars in dialysis

authors： Kalman RS,Pedrosa MC

更新日期：2015-01-01 00:00:00

abstract：:The control of serum phosphorus by dialysis is made difficult by the fact that intradialytic blood levels tend to be low, and because phosphorus is removed almost exclusively from the plasma during its passage through the dialyzer. The most practical way to increase phosphorus removal is to extend dialysis time, altho...

journal_title：Seminars in dialysis

authors： Daugirdas JT

更新日期：2015-11-01 00:00:00

abstract：:Mounting evidence supports a strong association between fluid management and outcomes among individuals receiving maintenance hemodialysis. The speed of fluid removal during dialysis (ultrafiltration, UF) is a modifiable aspect of fluid management that has attracted recent attention as a potential performance measure ...

journal_title：Seminars in dialysis

authors： Flythe JE

更新日期：2016-11-01 00:00:00

abstract：:Numerous designs for tunneled hemodialysis catheter have been developed in an effort to improve catheter function and survival. In this prospective randomized controlled study, 97 patients were randomized into the palindrome catheter group (PC, n = 47) and step-tip catheter group (SC, n = 50). Demographic characterist...

journal_title：Seminars in dialysis

authors： Hwang HS,Kang SH,Choi SR,Sun IO,Park HS,Kim Y

更新日期：2012-09-01 00:00:00

abstract：:The 180 l of glomerular filtrate formed each day contain some 1100 g (2.5 pounds) of sodium chloride, of which only 5-10 g are excreted in the urine--95% is reabsorbed by the tubules. Some 425 g (nearly a pound) of sodium bicarbonate and 145 g of glucose are filtered, and more than 99% of both are reabsorbed. Also fil...

journal_title：Seminars in dialysis

authors： Weisberg LS,Zanger R

更新日期：2010-11-01 00:00:00

abstract：:The majority of end-stage renal disease (ESRD) patients are hypertensive. Drug therapy for hypertension in hemodialysis (HD) patients includes all classes of antihypertensive drugs, with the sole exception of diuretics. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers may decrease mo...

journal_title：Seminars in dialysis

authors： Hörl MP,Hörl WH

更新日期：2004-07-01 00:00:00

abstract：:Cardiac resynchronization therapy with or without a defibrillator (CRT(D)) and implantable cardioverter defibrillator (ICD) may reduce the risk of arrhythmia or heart failure-specific mortality and improves the prognosis of patients with chronic kidney disease (CKD) or dialysis. The aim of this study was to perform a ...

journal_title：Seminars in dialysis

authors： Liu Y,Sun JY,Zhu YS,Li ZM,Li KL,Wang RX

更新日期：2020-12-09 00:00:00

abstract：:For patients who require hemodialysis, beta blockers offer a simultaneous opportunity and challenge in the treatment of cardiovascular disease. Beta blockers are well supported by data from nondialysis populations and directly mitigate the sympathetic overactivity that links chronic kidney disease with cardiovascular ...

journal_title：Seminars in dialysis

authors： Weir MA,Herzog CA

更新日期：2018-05-01 00:00:00

abstract：:Recent experimental and clinical studies suggest the possible utility of niacin (nicotinic acid, vitamin B3) and its metabolite nicotinamide as a means of lowering phosphate levels in dialysis patients via direct inhibition of the Na-Pi-2b sodium-dependent phosphate co-transporter in the GI tract. While the possibilit...

journal_title：Seminars in dialysis

authors： Berns JS

更新日期：2008-05-01 00:00:00